Intron Biotechnology Inc. | Balance Sheet
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
6,926
16,865
13,734
28,336
23,981
Total Accounts Receivable
2,852
3,215
4,292
5,034
5,692
Inventories
687
641
952
1,099
1,169
Other Current Assets
112
295
278
288
259
Total Current Assets
10,578
21,016
19,256
34,757
31,101
Net Property, Plant & Equipment
3,372
3,014
6,636
7,753
7,922
Total Investments and Advances
185
708
3,192
2,886
2,430
Long-Term Note Receivable
50
50
-
-
30
Intangible Assets
7,645
8,482
9,966
12,297
13,416
Other Assets
594
218
346
753
821
Total Assets
23,207
34,400
40,370
59,606
56,533
ST Debt & Current Portion LT Debt
3,704
268
1,711
1,339
3,996
Accounts Payable
412
173
559
217
315
Other Current Liabilities
612
730
998
6,550
9,511
Total Current Liabilities
4,728
1,170
3,268
8,106
13,822
Long-Term Debt
396
13,152
1,747
1,548
552
Provision for Risks & Charges
346
304
448
409
334
Deferred Taxes
782
913
974
1,159
813
Other Liabilities
252
386
38
42
42
Total Liabilities
5,723
15,012
5,500
10,105
14,750
Common Equity (Total)
17,484
19,389
34,442
49,150
41,148
Total Shareholders' Equity
17,484
19,389
34,442
49,150
41,148
Total Equity
17,484
19,389
34,442
49,150
41,201
Liabilities & Shareholders' Equity
23,207
34,400
40,370
59,606
56,533
Accumulated Minority Interest
-
-
-
-
53
Non-Equity Reserves
-
-
428
351
581
About Intron Biotechnology
View Profile
